Your browser doesn't support javascript.
loading
Harringtonine Ester Derivatives with Enhanced Antiproliferative Activities against HL-60 and HeLa Cells.
Ochi, Akihiro; Yoritate, Makoto; Miyamoto, Tomofumi; Usui, Kazuteru; Yusakul, Gorawit; Putalun, Waraporn; Tanaka, Hiroyuki; Hirai, Go; Morimoto, Satoshi; Sakamoto, Seiichi.
Afiliação
  • Ochi A; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Yoritate M; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Miyamoto T; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Usui K; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Yusakul G; Faculty of Pharmaceutical Sciences, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo 194-8543, Japan.
  • Putalun W; School of Pharmacy, Walailak University, Nakhon Si Thammarat 80160, Thailand.
  • Tanaka H; Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.
  • Hirai G; Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, 1-1-1 Daigaku-dori, Sanyo-Onoda City, Yamaguchi 756-0884, Japan.
  • Morimoto S; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Sakamoto S; Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
J Nat Prod ; 85(2): 345-351, 2022 02 25.
Article em En | MEDLINE | ID: mdl-35148094
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda / Harringtoninas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda / Harringtoninas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article